Neuland Laboratories Limited reported its financial performance for the quarter ended December 31, 2024, showcasing a strong increase in net profit and stable revenue growth, driven by operational efficiencies and cost management.
Key Financial Highlights (Q3 FY25):
- Revenue from Operations: ₹398.03 crore, a slight increase of 1.3% compared to ₹392.83 crore in Q3 FY24.
- Total Income: ₹401.94 crore, up from ₹394.93 crore in the same period last year.
- Net Profit: The company posted a net profit of ₹101.59 crore, up 24.9% compared to ₹81.39 crore YoY. The improvement in profitability was supported by lower operational costs and higher efficiency gains.
Expense Overview:
- Cost of Materials Consumed: ₹145.44 crore, down from ₹153.45 crore in Q3 FY24, reflecting efficient procurement and production optimization.
- Employee Benefits Expense: ₹69.34 crore, up from ₹65.73 crore YoY.
- Finance Costs: ₹2.22 crore compared to ₹3.74 crore YoY.
- Depreciation and Amortization: ₹16.30 crore, marginally higher than ₹15.14 crore in the corresponding quarter.
Profitability and Margins:
- Profit Before Tax: ₹127.76 crore, up from ₹104.48 crore YoY, highlighting an improved bottom line due to strategic cost control measures.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your research or consult a financial advisor before making investment decisions.
